XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 25, 2022
Jun. 26, 2021
Jun. 25, 2022
Jun. 26, 2021
Revenues:        
Total revenues $ 11,909,032 $ 9,905,256 $ 23,487,454 $ 21,581,624
Expenses:        
Cost of product revenues 7,906,250 6,044,543 15,689,129 12,441,213
Research and development 5,145,375 3,740,253 10,553,988 7,303,553
Selling, general and administration 4,327,468 4,040,979 8,792,016 9,946,685
Total expenses 17,379,093 13,825,775 35,035,133 29,691,451
Loss from operations (5,470,061) (3,920,519) (11,547,679) (8,109,827)
Other (expense) income        
Interest income 12,552 3,541 19,532 12,285
Other expense, net (3,586) (896) (4,727) (2,045)
Gain on investments 4,700,000
Foreign currency transaction (losses) gains (150,094) 100,991 (114,979) 129,981
Total other (expense) income (141,128) 103,636 4,599,826 140,221
Loss before provision for income taxes and net loss attributable to noncontrolling interest (5,611,189) (3,816,883) (6,947,853) (7,969,606)
Tax provision (36,000) (32,000) (72,000) (65,000)
Net loss (5,647,189) (3,848,883) (7,019,853) (8,034,606)
Net loss attributable to the noncontrolling interest 257 16 280 39,501
Net loss attributable to Kopin Corporation $ (5,646,932) $ (3,848,867) $ (7,019,573) $ (7,995,105)
Net loss per share        
Basic and diluted $ (0.06) $ (0.04) $ (0.08) $ (0.09)
Weighted average number of common shares outstanding        
Basic and diluted 90,300,999 88,815,356 90,211,742 88,096,822
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 9,003,658 $ 6,928,819 $ 15,511,186 $ 14,497,663
Research and Development and Other Revenues [Member]        
Revenues:        
Total revenues $ 2,905,374 $ 2,976,437 $ 7,976,268 $ 7,083,961